Factors influencing breath condensate volume

 

 Permissions and Reprints

Abstract

Analysis of breath condensate (BC) has received interest recently due to the need for easy and repetitive monitoring of airway and pulmonary disease. While many authors have used custom built systems, commercial systems are now available and will probably be used more widely. Early studies of markers and mediators in BC have reported concentrations following varying periods of sampling time. However, factors that influence the generation of BC have not been analysed and it is unclear whether breathing rate, tidal volume, lung function, body weight, height or age influence the amount of BC collected. We therefore studied the influence of these factors on breath condensate volume and breath condensate urea and protein concentrations in 22 healthy volunteers and 23 COPD patients.

A strong correlation of total respired volume and breath condensate volume was observed for both groups (volunteers: r = 0.952, p < 0.0001, COPD: r = 0.883, p < 0.0001) while no significant correlation existed for breath condensate volume and TLC, RV, VC, FEV1, R_tot, height or body weight. As long as ventilation remained fairly constant, breath condensate volume increased linearly with time. The fraction of breath condensate extracted from total vapour contained in the exhalate was estimated by measuring relative atmospheric humidity before and after the collecting tube. The amount calculated by the change in temperature and saturation corresponded closely to the amount actually collected.

We conclude from these results that breath condensate volume is primarily dependent on V_E, and does not seem to depend on lung function parameters. For standardisation it is suggested to report breath condensate measurements per volume respired. Both, urea and protein are present in measurable quantities in breath condensate and protein as well as BCV may be helpful denominators for comparison with e. g. cytokines in lung disease.

References

• 1 Montuschi P, Kharitonov S A, Ciabattoni G, Corradi M, van Rensen L, Geddes D M, Hodson M E, Barnes P J. Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.  Thorax. 2000;  55 (3) 205-209
  CrossrefPubMedGoogle Scholar
• 2 Hunt J F, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills T A, Gaston B. Endogenous airway acidification. Implications for asthma pathophysiology.  Am J Respir Crit Care Med. 2000;  161 (3 Pt 1) 694-699
  PubMedGoogle Scholar
• 3 Loukides S, Horvath I, Wodehouse T, Cole P J, Barnes P J. Elevated levels of expired breath hydrogen peroxide in bronchiectasis.  Am J Respir Crit Care Med. 1998;  158 (3) 991-994
  PubMedGoogle Scholar
• 4 Gessner C, Seyfarth H J, Hoheisel G, Winkler J, Hillebrand T, Schauer J. Identification of K-ras gene mutations in breathing condensate of patients with non small cell lung cancer (NSCLC) as a non-invasive method for screening (abstract).  Am J Respir Crit Care Med. 1998;  157 A693
  PubMedGoogle Scholar
• 5 Gessner C. Detection of mutations of the K-ras gene in condensed breath of patients with non-small-cell lung carcinoma (NSCLC) as a possible noninvasive screening method.  Pneumologie. 1998;  52(7) 426-427
  PubMedGoogle Scholar
• 6 Hillebrand T, Bendzko P, Beck E, Becher G, Roth M, Neubauer G, Norpoth K, Stresemann E. Isolation of DNA from breathing condensate (abstract).  Am J Respir Crit Care Med. 1996;  153 A181
  PubMedGoogle Scholar
• 7 Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov S A, Barnes P J. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.  Am J Respir Crit Care Med. 1999;  160 (1) 216-220
  PubMedGoogle Scholar
• 8 Becher G, Winsel K, Beck E, Neubauer G, Stresemann E. Breath condensate as a method of noninvasive assessment of inflammation mediators from the lower airways.  Pneumologie. 1997;  51 (Supp 2) 456-459
  PubMedGoogle Scholar
• 9 Antczak A, Nowak D, Bialasiewicz P, Kasielski M. Hydrogen peroxide in expired air condensate correlates positively with early steps of peripheral neutrophil activation in asthmatic patients.  Arch Immunol Ther Exp (Warsz). 1999;  47(2) 119-126
  PubMedGoogle Scholar
• 10 Dekhuijzen P N, Aben K K, Dekker I, Aarts L P, Wielders P L, van Herwaarden C L, Bast A. Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 1996;  154 (3 Pt 1) 813-816
  CrossrefPubMedGoogle Scholar
• 11 Horvath I, Loukides S, Wodehouse T, Kharitonov S A, Cole P J, Barnes P J. Increased levels of exhaled carbon monoxide in bronchiectasis: a new marker of oxidative stress.  Thorax. 1998;  53 (10) 867-870
  PubMedGoogle Scholar
• 12 Kietzmann D, Kahl R, Muller M, Burchardi H, Kettler D. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS.  Intensive Care Med. 1993;  19 (2) 78-81
  CrossrefPubMedGoogle Scholar
• 13 Sznajder J I, Fraiman A, Hall J B, Sanders W, Schmidt G, Crawford G, Nahum A, Factor P, Wood L D. Increased hydrogen peroxide in the expired breath of patients with acute hypoxemic respiratory failure.  Chest. 1989;  96 (3) 606-612
  PubMedGoogle Scholar
• 14 Nowak D, Antczak A, Krol M, Pietras T, Shariati B, Bialasiewicz P, Jeczkowski K, Kula P. Increased content of hydrogen peroxide in the expired breath of cigarette smokers.  Eur Respir J. 1996;  9 (4) 652-657
  CrossrefPubMedGoogle Scholar
• 15 Scheideler L, Manke H G, Schwulera U, Inacker O, Hammerle H. Detection of nonvolatile macromolecules in breath.  A possible diagnostic tool? Am Rev Respir Dis. 1993;  148 (3) 778-784
  PubMedGoogle Scholar
• 16 Haslam P L, Baughman R P. Report of ERS Task Force: Guidelines for measurement of acellular components and standardization of BAL [editorial].  Eur Respir J. 1999;  14 (2) 245-248
  PubMedGoogle Scholar
• 17 von Vogel H U. Chemiker-Kalender, 1th ed. Springer-Verlag, Berlin, Göttingen,Heidelberg 1956
  Google Scholar
• 18 Smith P K, Krohn R I, Hermanson G T, Mallia A K, Gartner F H, Provenzano M D, Fujimoto E K, Goeke N M, Olson B J, Klenk D C. Measurement of protein using bicinchoninic acid.  Anal Biochem. 1985;  150 (1) 76-85
  PubMedGoogle Scholar
• 19 Wiechelman K J, Braun R D, Fitzpatrick J D. Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation.  Anal Biochem. 1988;  175 (1) 231-237
  CrossrefPubMedGoogle Scholar
• 20 Reinhold P, Langenberg A, Becher G, Rothe M. Breath condensate - a medium obtained by a noninvasive method for the detection of inflammation mediators of the lung.  Berl Munch Tierarztl Wschr. 1999;  112 (6-7) 254-259
  PubMedGoogle Scholar

Dr. Christian Gessner

Medizinische Klinik und Poliklinik I
Universitätsklinikum Leipzig

Johannisallee 32

04103 Leipzig

Email: gesc@medizin.uni-leipzig.de